Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
2,218.00
1,907.00
1,691.00
1,394.00
1,009.00
1,092.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,218.00
1,907.00
1,691.00
1,394.00
1,009.00
1,092.00
Expenditure (Ex Depriciation)
Stock Adjustments
-9.00
-3.00
-8.00
-6.00
2.00
3.00
Raw Materials Consumed
590.00
479.00
432.00
360.00
238.00
236.00
Power & Fuel Cost
43.00
39.00
36.00
34.00
31.00
33.00
Employee Cost
353.00
308.00
275.00
233.00
195.00
208.00
Operating Expenses
577.00
499.00
81.00
64.00
57.00
54.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
46.00
40.00
33.00
18.00
13.00
19.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
33.00
34.00
26.00
22.00
12.00
11.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,835.00
1,582.00
1,395.00
1,159.00
886.00
923.00
Operating Profit (PBDIT) excl Other Income
382.00
325.00
295.00
234.00
122.00
168.00
Other Income
39.00
21.00
16.00
15.00
21.00
10.00
Operating Profit (PBDIT)
422.00
346.00
311.00
250.00
143.00
179.00
Interest
154.00
108.00
103.00
97.00
119.00
137.00
Profit before Depriciation and Tax
267.00
237.00
208.00
152.00
24.00
41.00
Depreciation
211.00
174.00
163.00
158.00
159.00
148.00
Profit Before Taxation & Exceptional Items
56.00
63.00
44.00
-5.00
-134.00
-106.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
56.00
67.00
44.00
87.00
-228.00
-119.00
Provision for Tax
8.00
26.00
27.00
48.00
-7.00
6.00
Profit After Tax
48.00
40.00
17.00
40.00
-220.00
-113.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
-496.00
-452.00
-436.00
-475.00
-292.00
0.00
Profit Available for appropriations
-451.00
-404.00
-407.00
-421.00
-485.00
0.00
Appropriations
-451.00
-404.00
-407.00
-421.00
-485.00
0.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
3.19
3.46
2.11
4.14
-17.02
-12.05
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 16.26% vs 12.80% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 17.59% vs 10.04% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 42.14% vs 5.06% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 17.38% vs 132.01% in Mar 2024
Compare Profit and Loss Results of Health.Global
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,218.00
1,296.00
922.00
71.14%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,218.00
1,296.00
922.00
71.14%
Expenditure (Ex Depriciation)
Stock Adjustments
-9.00
0.00
-9.00
0%
Raw Materials Consumed
590.00
165.00
425.00
257.58%
Power & Fuel Cost
43.00
26.00
17.00
65.38%
Employee Cost
353.00
176.00
177.00
100.57%
Operating Expenses
577.00
95.00
482.00
507.37%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
46.00
29.00
17.00
58.62%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
33.00
4.00
29.00
725.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,835.00
864.00
971.00
112.38%
Operating Profit (PBDIT) excl Other Income
382.00
432.00
-50.00
-11.57%
Other Income
39.00
37.00
2.00
5.41%
Operating Profit (PBDIT)
422.00
469.00
-47.00
-10.02%
Interest
154.00
62.00
92.00
148.39%
Profit before Depriciation and Tax
267.00
406.00
-139.00
-34.24%
Depreciation
211.00
112.00
99.00
88.39%
Profit Before Taxation & Exceptional Items
56.00
294.00
-238.00
-80.95%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
56.00
294.00
-238.00
-80.95%
Provision for Tax
8.00
76.00
-68.00
-89.47%
Profit After Tax
48.00
218.00
-170.00
-77.98%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-496.00
555.00
-1,051.00
-189.37%
Profit Available for appropriations
-451.00
772.00
-1,223.00
-158.42%
Appropriations
-451.00
772.00
-1,223.00
-158.42%
Equity Dividend (%)
0%
30%
-30.00
Earnings Per Share
3.19
21.38
-18.19
-85.08%
Profit And Loss - Net Sales
Net Sales 2,218.14 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.26% vs 12.80% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 382.57 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.59% vs 10.04% in Mar 2024
Profit And Loss - Interest
Interest 154.56 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.14% vs 5.06% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 48.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.38% vs 132.01% in Mar 2024






